AM Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of "a-" to Niva Bupa Health Insurance Company Limited . The agency also awarded an India National Scale Rating of aaa.IN (Exceptional) with a stable outlook.

The ratings reflect the insurer’s very strong balance sheet, adequate operating performance, and neutral business profile. AM Best noted that the ratings incorporate enhancement from the company’s parent, British United Provident Association Limited (Bupa Group).

Capital and Balance Sheet Strength

Niva Bupa’s balance sheet strength is underpinned by its risk-adjusted capitalisation, measured by Best’s Capital Adequacy Ratio (BCAR), which was at the strongest level as of fiscal year-end March 31, 2026. AM Best expects this capitalisation level to remain strong, supported by internal capital generation and earnings retention.

The company maintains strong financial flexibility through shareholder capital contributions and access to debt markets. Its investment portfolio is low-risk, with the majority of assets allocated to fixed-income securities of good credit quality.

Operating Performance and Metrics

AM Best assesses operating performance as adequate, noting positive earnings over the last four years (FY23-FY26). While robust investment returns have offset underwriting losses, underwriting performance has improved materially in recent years due to a lower expense ratio driven by operational scale expansion.

In FY26, Niva Bupa recorded a return-on-equity ratio of 10.7% and a combined ratio of 102.0% (net/net, IFRS 17).

Business Profile and Parent Support

Ranked third in India’s standalone health insurance sector, Niva Bupa holds a solid position in the retail health segment with diversified distribution channels and digital capabilities. The rating enhancement reflects majority ownership by Bupa Group, which provides explicit and implicit support, including shared resources and expected capital support as needed.

What the Numbers Show

The divergence between the positive return on equity (10.7%) and the combined ratio above 100% (102.0%) indicates that underwriting operations incurred a loss. This structural reliance on investment income to generate overall profitability highlights the critical role of the company’s low-risk, fixed-income heavy investment portfolio in sustaining earnings despite underwriting pressures.

Niva Bupa Health Insurance Company appointed Karan Bhatia as chief investment officer effective September 16, 2026. The move coincides with Vikas Jain transitioning to the role of chief transformation officer.

The company disclosed the change in senior management under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Both appointments took effect immediately on the filing date.

Leadership Changes

Vikas Jain ceases his tenure as chief investment officer after holding the position since October 2020. He joins the senior management team as chief transformation officer. Jain has been associated with the company since September 2015.

Karan Bhatia assumes the chief investment officer role, bringing over 18 years of experience in the investment domain. He joined the company’s treasury and investments team as a fund manager in December 2015.

Profile Details

Bhatia holds a post-graduation in finance from Kirloskar Institute of Management. Prior to joining Niva Bupa, he worked with Canara HSBC Life Insurance, Axis Maxlife Insurance, Future Generali Life Insurance and Pipl Research & Analytics.

His responsibilities include overseeing the investment portfolio, generating superior risk-adjusted returns, ensuring capital protection and maintaining adequate liquidity while adhering to regulatory compliance.

The company confirmed no relationships exist between directors regarding these appointments.